These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28124523)

  • 1. Predictive role of Trimprob associated with multiparametric MRI in the diagnosis of prostate cancer.
    Guimaraes GC; Costa WH; Rosa RA; Zequi S; Favaretto R
    Int Braz J Urol; 2017; 43(1):29-35. PubMed ID: 28124523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?
    Panebianco V; Barchetti G; Simone G; Del Monte M; Ciardi A; Grompone MD; Campa R; Indino EL; Barchetti F; Sciarra A; Leonardo C; Gallucci M; Catalano C
    Eur Urol; 2018 Jul; 74(1):48-54. PubMed ID: 29566957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?
    Pepe P; Garufi A; Priolo G; Pennisi M
    Clin Genitourin Cancer; 2015 Feb; 13(1):e27-30. PubMed ID: 25081324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric magnetic resonance imaging predicts the presence of prostate cancer in patients with negative prostate biopsy.
    Lista F; Castillo E; Gimbernat H; Rodríguez-Barbero JM; Panizo J; Angulo JC
    Actas Urol Esp; 2015 Mar; 39(2):85-91. PubMed ID: 25267460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy.
    Pepe P; Garufi A; Priolo G; Dibenedetto G; Salemi M; Pennisi M; Fraggetta F; Aragona F; Barbera M
    Arch Ital Urol Androl; 2014 Dec; 86(4):336-9. PubMed ID: 25641466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.
    Tubaro A; De Nunzio C; Trucchi A; Stoppacciaro A; Miano L
    Urology; 2008 Aug; 72(2):340-4. PubMed ID: 18336888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.
    Mussi TC; Garcia RG; Queiroz MR; Lemos GC; Baroni RH
    Int Braz J Urol; 2016; 42(5):897-905. PubMed ID: 27532112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-resonance interaction method for the noninvasive diagnosis of prostate cancer: analysis of a multicentre clinical evaluation.
    Da Pozzo L; Scattoni V; Mazzoccoli B; Rigatti P; Manferrari F; Martorana G; Pietropaolo F; Belgrano E; Prezioso D; Lotti T; Villari D; Nicita G
    BJU Int; 2007 Nov; 100(5):1055-9. PubMed ID: 17711511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of PCA3 and multiparametric MRI's: collective benefits before deciding initial prostate biopsy for patients with PSA level between 3-10ng/mL.
    Okcelik S; Soydan H; Ates F; Berber U; Saygin H; Sonmez G; Karademir K
    Int Braz J Urol; 2016; 42(3):449-55. PubMed ID: 27286106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance.
    Sahibzada I; Batura D; Hellawell G
    Int Urol Nephrol; 2016 Apr; 48(4):529-33. PubMed ID: 26759330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology.
    Tsivian M; Gupta RT; Tsivian E; Qi P; Mendez MH; Abern MR; Tay KJ; Polascik TJ
    Int J Urol; 2017 Feb; 24(2):137-143. PubMed ID: 27859637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.
    Tran M; Thompson J; Böhm M; Pulbrook M; Moses D; Shnier R; Brenner P; Delprado W; Haynes AM; Savdie R; Stricker PD
    BJU Int; 2016 Jan; 117(1):48-54. PubMed ID: 25682968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Resonance Interaction Method (TRIMprob) has the potential to be used alongside the recognized tests in the screening protocols for prostate cancer.
    Gokce O; Sanli O; Salmaslioglu A; Tunaci A; Ozsoy C; Ozcan F
    Int J Urol; 2009 Jun; 16(6):580-3. PubMed ID: 19456986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI
    Drudi FM; Cantisani V; Angelini F; Ciccariello M; Messineo D; Ettorre E; Liberatore M; Scialpi M
    Anticancer Res; 2019 Jun; 39(6):3101-3110. PubMed ID: 31177155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.
    Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD
    Eur Urol Focus; 2019 Jul; 5(4):585-591. PubMed ID: 29102671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
    Jambor I; Kähkönen E; Taimen P; Merisaari H; Saunavaara J; Alanen K; Obsitnik B; Minn H; Lehotska V; Aronen HJ
    J Magn Reson Imaging; 2015 May; 41(5):1394-404. PubMed ID: 24956412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting.
    Grey AD; Chana MS; Popert R; Wolfe K; Liyanage SH; Acher PL
    BJU Int; 2015 May; 115(5):728-35. PubMed ID: 25041307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.